Miorel (Thiocolchicoside)

Thiocolchicoside, the active ingredient in Miorel, is a muscle relaxant presented as an injectable solution for intramuscular use. It is employed to relieve muscle spasm and associated musculoskeletal pain, primarily in adult patients.

GNH USA supplies Miorel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is distributed under strict regulatory oversight.

Thiocolchicoside is indicated for conditions involving skeletal muscle spasm and related pain, often in acute or sub‑acute settings.

- Muscle spasm: provides rapid relief of involuntary muscle contraction and associated discomfort. - Acute low back pain: helps reduce pain and improve functional mobility during short‑term episodes. - Musculoskeletal pain: alleviates pain linked to muscle strain or injury, supporting recovery.

Adverse reactions may occur with intramuscular administration of thiocolchicoside.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Nausea: transient feeling of queasiness. - Dizziness: occasional light‑headed sensation. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness. - Mild skin rash: limited erythema or itching.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty. - Hepatotoxicity: signs of liver injury such as jaundice. - Severe hypotension: marked drop in blood pressure. - Seizures: rare occurrence of convulsive episodes. - Agranulocytosis: dangerously low white‑blood‑cell count. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.

Before using thiocolchicoside, consider the following safety measures.

- Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown excretion; use with caution. - Elderly patients: monitor for increased sensitivity to muscle relaxation. - Renal or hepatic impairment: dose adjustment may be required. - Concomitant CNS depressants: assess for additive sedation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Thiocolchicoside may interact with several drug classes; review patient medication lists.

Major Interactions (Avoid): - Neuromuscular blocking agents: may potentiate muscle weakness. - CNS depressants (e.g., benzodiazepines): risk of excessive sedation.

Moderate Interactions (Monitor Closely): - Antihistamines: possible additive drowsiness. - Antiepileptic drugs: may alter seizure threshold. - CYP450 inhibitors: potential increase in plasma levels. - Diuretics: monitor electrolyte balance. - Anticoagulants: observe for bleeding at injection site.